Disulfiram reduces elevated blood glucose levels in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes

Journal of Oleo Science

Volumn 58, Issue 9, 2009, Pages 485-490

  Nagai, Noriaki ^a   Murao, Takatoshi ^a   Okamoto, Norio ^b   Ito, Yoshimasa ^a  

^a KINKI UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Disulfiram; Glucose; Insulin; Otsuka Long Evans Tokushima Fatty rat; Type 2 diabetes mellitus

Indexed keywords

EID: 68949148575     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.58.485     Document Type: Article

References (27)

1. King, H.; Aubert, R.E.; Herman, W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414-1431 (1998).
2. Yoon, K.H.; Lee, J.H.; Kim, J.W.; Cho, J.H.; Choi, Y.H.; Ko, S.H.; Zimmet, P.; Son, H.Y. Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681-1688 (2006).
3. Schrauwen, P.; Hesselink, M.K. Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus? Diabetologia 51, 1694-1697 (2008).
4. Porte, D. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40, 166-180 (1991).
5. DeFronzo, R.A.; Bonadonna, R.C.; Ferrannini, E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368 (1992).
6. Yki, J.H. Glucose toxicity. Endocrine. Rev. 13, 415-431 (1992).
7. Vinik, A.; Pittenger, G.; Rafaeloff, R.; Rosenberg, L.; Duguid, W. Determinants of pancreatic islet cell mass: A balance between neogenesis and senescence/apoptosis. Diabetes Rev. 4, 235-263 (1996).
8. Matsuoka, T.; Kajimoto, Y.; Watada, H.; Kaneto, H.; Kishimoto, M.; Umayahara, Y.; Fujitani, Y.; Kamada, T.; Kawamori, R.; Yamasaki, Y. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99, 144-150 (1997).
9. Kaneto, H.; Fujii, J.; Myint, T.; Miyazawa, N.; Islam, K.N.; Kawasaki, Y.; Suzuki, K.; Nakamura, M.; Tatsumi, H.; Yamasaki, Y.; Taniguchi, N. Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem. J. 320, 855-863 (1996).
10. Tiedge, M.; Lortz, S.; Drinkgern, J.; Lenzen, S. Diabetes 46, 1733-1742 (1997).
11. Carlsson, S.; Hammar, N.; Efendic, S.; Persson, P.G.; Ostenson, C.G.; Grill, V. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabet. Med. 17, 776-781 (2000).
12. Laws, A.; Terry, R.B.; Barrett, C.E. Behavioral covariates of waist-to-hip ratio in Rancho Bernardo. Am. J. Public Health 80, 1358-1362 (1990).
13. Björntorp, P. Abdominal fat distribution and disease: An overview of epidemiological data. Ann. Med. 24, 15-18 (1992).
14. th edn. (Gilman, A.G.; Rall, T.W.; Nies, A.S.; Taylor, P. ed.). Perfamon Press. New York. pp.378-379 (1990).
15. Nabekura, T.; Koizumi, Y.; Nakao, M.; Tomohiro, M.; Inomata, M.; Ito, Y. Delay of cataract development in hereditary cataract UPL rats by disulfiram and aminoguanidine. Exp. Eye Res. 76, 169-174 (2003).
16. Ito, Y.; Cai, H.; Koizumi, Y.; Nakao, M.; Terao, M. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats. Curr. Eye Res. 18, 292-299 (1999).
17. Kawano, K.; Hirashima, T.; Mori, S.; Saitoh, Y.; Kurosumi, M.; Natori, T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41, 1422-1428 (1992).
18. Ishida, K.; Mizuno, A.; Min, Z.; Sano, T.; Shima, K. Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism 44, 940-945 (1995).
19. Sato, T.; Asahi, Y.; Toide, K.; Nakayama, N. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM. Diabetologia 38, 1033-1041 (1995).
20. Yabuki, A.; Tahara, T.; Taniguchi, K.; Matsumoto, M.; Suzuki, S. Neuronal nitric oxide synthase and cyclooxygenase-2 in diabetic nephropathy of type 2 diabetic OLETF rats. Exp. Anim. 55, 17-25 (2006).
21. DeFronzo, R.A.; Ferrannini, E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173-194 (1991).
22. Tajiri, Y.; Moller, C.; Grill, V. Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function. Endocrinology 138, 273-280 (1997).
23. Kaneto, H.; Kajimoto, Y.; Fujitani, Y.; Matsuoka, T.; Sakamoto, K.; Matsuhisa, M.; Yamasaki, Y.; Hori, M. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia 42, 1093-1097 (1999).
24. Kaneto, H.; Kajimoto, Y.; Miyagawa, J.; Matsuoka, T.; Fujitani, Y.; Umayahara, Y.; Hanafusa, T.; Matsuzawa, Y.; Yamasaki, Y.; Hori, M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48, 2398-2406 (1999).
25. Hirashima, T.; Man, Z.W.; Mori, S.; Kawano, K. OLETF rat. Diabetes Frontier 9, 477-480 (1998).
26. Minami, A.; Ishimura, N.; Sakamoto, S.; Takishita, E.; Mawatari, K.; Okada, K.; Nakaya, Y. Effect of eicosapentaenoic acid ethyl ester v. oleic acid-rich safflower oil on insulin resistance in type 2 diabetic model rats with hypertriacylglycerolaemia. Br. J. Nutr. 87, 157-162 (2002).
27. Sadur, C.N.; Eckel, R.H. Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. J. Clin. Invest. 69, 1119-1125 (1982).